INTRODUCTION
Now a day, a huge number of a heterocyclic compound discovered through various eco-friendly methods like onepot multicomponent reaction, ultrasonic irradiations technique or Diels-Alder reactions. 1-3 Tetrahydroquinoline and pyrimidine derivatives are broadly used in medicinal chemistry. They showed a huge number of important biological properties such as antimicrobial, [4] [5] [6] [7] antimalarial, [8] [9] [10] analgesic, 11 anthelmintic, 12 antitumor, 13 antiinflammatory, 14 antiviral [15] [16] [17] and anticancer 18 activity. Keeping the view of the biological importance of heterocyclic compounds, 19 we studied the biological activity of tetrahydroquinoline 20 pyrimidine, 21 thiazolone, 22 and benzenesulfonamide 23 derivatives.
EXPERIMENTAL
The starting materials and various solvents were commercially available (Sigma-Aldrich and Avra labs). Reaction courses were monitored by TLC on silica gel precoated F254 Merck plates. Developed plates were examined with UV lamps (254 nm). Melting points were recorded on SRS Optimelt, melting point apparatus and are uncorrected. IR spectra were recorded on an FT-IR (Bruker). 1 H NMR spectra were recorded on a 400 MHz Bruker spectrometer and were recorded in DMSO-d6 solvent 13 C NMR spectra were recorded in DMSO-d6 solvent on a 100 MHz Bruker spectrometer. Chemical shifts are reported as δ ppm units (TMS).
The following abbreviations are used; singlet (s), doublet (d), triplet (t), quartet (q), multiplet (m) and broad (br). Mass spectra were taken with Micromass-QUATTRO-II of WATER mass spectrometer.
General procedure for synthesis of tetrahydroquinoline derivatives
In around bottom flask, 4-aminonaphthalene (0.1 mol), aromatic aldehyde (0.1 mol), dihydrofurane (DHF) (0.1 mol) and catalyst -InCl3 (20 mol %) in EtOH as solvent (5 mL) were refluxed at for 7 h. The reaction condition was checked by employing TLC technique, using ethyl acetate: hexane (5:5) as solvents. After completing reaction, reaction mixture was cooled at room temperature. For crystallization, 10 mL methanol was added to the reaction mixture and then cooled at 22 °C, following stirring for 20 minutes. Products were filtered using G1 sintered crucible. Products were recrystallized from ethyl alcohol. 
General procedure for pyrimidine derivatives
In the ultrasound-assisted method, a mixture of piperidine (10 mol %), isoniazide (0.1 mol), aldehyde (0.1 mol) and maleic anhydride (0.1 mol) in dichloroethane (DCE) as solvent (5 mL) was irradiated with ultrasound (with a frequency of 50 Hz and power of 250 V AC) at 70 o C for 2 h. The reaction progress was checked on TLC using ethyl acetate:hexane (5:5) as solvents. After the completion of reaction, the mixture was cooled at room temperature. Charged methanol (10 mL) was used for crystallization and then the mixture was cooled to 22 o C and stirred for 30 min. The product was filzterd with G1 sintered crucible and recrystallized from ethyl alcohol. 1,3(3aH,11aH) -1,3(3aH,11aH) -1,3(3aH,11aH) (2,3-Dihydroxyphenyl)-5a,6-dicyclobenzo[4,5]imidazo[1,2a]furo[3,4-e]pyrimidine-1,3(3aH,11aH) 
4-(3-Bromophenyl)-5a,6-dicyclobenzo[4,5]imidazo[1,2-a]furo[3,4-e]pyrimidine 1,3(3aH,11aH)-dione (5h)

4-(4-Chlorophenyl)-5a,6-dicyclobenzo[4,5]imidazo[1,2-a]furo[3,4-e]pyrimidine
4-(2,4-Dichlorophenyl)-5a,6-dicyclobenzo[4,5]imidazo[1,2-a]furo[3,4-e]pyrimidine
4-(4-Nitrophenyl)-5a,6-dicyclobenzo[4,5]imidazo[1,2a]furo[3,4-e]pyrimidine
4-
Biological activity
The in-vitro antimicrobial activity has been studied by a disc diffusion method or Kirby-Bauer method 24 with different strains of bacteria and fungi. Gentamicin and amphotericin B were used as positive controls for bacteria and fungi, respectively. The compounds were screened for antibacterial activity against E. coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853 and StaphylococcusaureusATCC 25923 in Mueller-Hinton agar (M173) medium, and for antifungal activity against Candida sp. in Sabouraud's dextrose agar medium. The plates were incubated at 37 °C for 24 h for both antibacterial and antifungal activities.
The in-vitro antituberculosis activity has been carried out by CLAIRO COMBI method 25 with tuberculosis bacteria and Streptomycin was used as a positive control. Liquefied sterile Lowenstein-Jensen agar is poured into Petri dishes kept on the level surface. Media depth was 4 mm. After solidification, the dishes were dried for 30 min in an incubator at 37 °C to remove excess moisture from the surface. While pouring into the plates, 5 % defibrinated sterile blood was added to the test organism. The plates were incubated at 37 °C for 4 days.
In vitro anti-inflammatory activity measurement (human red-blood-cell (HRBC) membrane stabilization method): Fresh whole human blood (5mL) are collected and transferred to the centrifuged tubes containing Heparin or EDTA or sodium citrate to prevent clotting. The tubes are centrifuged at 3000 rpm for 10 min and are washed three times with equal volume of normal saline. The volume of the blood is measured and reconstituted as 10% v/v suspension with normal saline. The reaction mixture consists of 1.0mL of a test sample of different concentrations in normal saline and 0.5mL of 10% HRBC suspension, 1 mL of 0.2 M phosphate buffer, 1 ml hypo saline were incubated at 37 o C for 30 min and centrifuged at 3,000 rpm for 30 mins. The hemoglobin content of the supernatant solution was estimated spectrophotometrically at 560 nm. Diclofenac was used as a control. [26] [27] [28] [29] First, imines (Schiff bases) form from the 4aminonaphthalene (1) or 2-aminobenzimidazole (6) and the aromatic aldehydes (2a-j) and these are cyclized with dihydrofurane (3) or maleic anhydride (7) into the appropriate condensed heterocycles (6 and 7, respectively). The synthesized tetrahydroquinoline (4a-j) and pyrimidine (5a-n) derivatives were characterized by FT-IR, 1 H NMR, 13 C NMR and mass spectroscopy techniques.
RESULTS AND DISCUSSION
The prepared compounds have been screened for antibacterial, antifungal, antituberculosis 32 and antiinflammatory activities and measured the zones showing complete inhabitation and record the diameters of zones to the nearest millimeter. The results are summarized in Tables  3 and 4 .
All tetrahydroquinoline derivatives (4a-j) showed antibacterial activity only against Staphylococcus aureus ATCC 25923 bacteria but did not show any activity against E. coli ATCC 25922 and Pseudomonas aeruginosa ATCC27853 or antifungal activity against Candida sp. All pyrimidine derivatives (5a-n) showed antibacterial activity only against Staphylococcus aureus ATCC 25923 bacteria, but not showed against E. coli ATCC 25922 and Pseudomonas aeruginosa ATCC27853. Two pyrimidine derivatives samples (5j and 5k) showed antifungal activity against Candida sp.
Antituberculosis activity
The tetrahydroquinoline derivatives (4a-j) do not show any antituberculosis activity, but all pyrimidine derivatives (5a-n) hadantituberculosisactivity. The compound 5k showed activity in the higher while 5a, 5h and 5i in the lower zone.
The percentage of HRBC hemolysis and membrane stabilization or protection was calculated by using the standard formula. The results can be seen in Tables 3 and 4 . In the tetrahydroquinoline-series, sample (4d) showed the highest percentage of HRBC membrane stabilization and sample (4h) showed the lowest rate of HRBC membrane stabilization.
In pyrimidine derivatives case, sample (5a) showed the highest percentage of HRBC membrane stabilization and sample (5c) showed the lowest rate of HRBC membrane stabilization. 5a 5b 5c 5d 5e 5f 5g 5h 5i 5j 5k 5l 5m 5n STD 
CONCLUSION
We have used an eco-friendly route for the preparation of new tetrahydroquinoline and pyrimidine derivatives and screened for their antibacterial against E. coli, Pseudomonas aeruginosa and Staphylococcus aureus, antifungal activity against Candida sp., anti-tuberculosis activity against tuberculosis bacteria and in vitro anti-inflammatory activity. We have concluded that these series of compounds certainly hold great promise toward good active leads in medicinal chemistry.
